PSJ Web Site
J-STAGE
  Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended.


J.Health Sci., 46(2), 132-141, 2000

Modification of Carbon Tetrachloride-Induced Hepatotoxicity by Clofibric Acid in Rats

Yoshihiro Yamakawa,a Takaaki Doi,a Katsuaki Kubota,a Hiroshi Okayachi,a Naomi Kudo,b and Yoichi Kawashima*,b

aResearch and Development Laboratories, Maruho Co., 1 Awatacho, Chudoji, Shimogyo-ku, Kyoto 600-8815, Japan and bFaculty of Pharmaceutical Science, Josai University, Keyakidai, Sakado, Saitama 350-0295, Japan

Effects of clofibric acid (p-chlorophenoxyisobutyric acid) on carbon tetrachloride (CCl4)-induced hepatocellular necrosis and fatty liver were investigated. Male Wistar rats were fed a diet containing 0.5% (w/w) clofibric acid for 7 days before the administration of CCl4 (1 ml/kg, p.o.) and the treatment with clofibric acid continued throughout the time course of the study. In rats given only CCl4, the serum activity of alanine aminotransferase (ALT) increased rapidly and reached a maximum level at 24 h after the administration of CCl4. The rats pretreated with clofibric acid exhibited a significantly lower serum level of ALT compared with the rats treated with CCl4 alone until 24 h following CCl4 dosing. However, the maximum level that was observed at 48 h after the administration of CCl4 to the rats pretreated with clofibric acid was similar to the highest level observed in the CCl4 alone group at 24 h after CCl4 dosing. The hepatic glycogen level steeply decreased at 3 h after the administration of CCl4 and reached the lowest level at 12 h preceding the definite appearance of necrosis, with gradual recovery noted by 96 h. An evident decrease in glycogen level was also noted in the group given clofibric acid throughout the time course. In rats treated with both CCl4 and clofibric acid (clofibric acid + CCl4), hepatic glycogen was exhausted from 3 h and the depletion lasted until 96 h after dosing of CCl4. The serum level of glucose was not increased, but rather decreased markedly after the administration of CCl4 in both the rats receiving CCl4 alone and in the rats treated with clofibric acid + CCl4. The hepatic content of triglyceride increased rapidly and reached a level about 5-fold greater than the control at 12 h after the administration, then the elevated level lasted until 96 h of the time course. The increase in the hepatic content of triglyceride induced by CCl4 was significantly suppressed by pretreatment with clofibric acid and returned to the basal level by 96 h after dosing of CCl4. The results of histopathological examination of liver sections stained by hematoxylin and eosin, and oil red O, were very consistent with the biochemical changes mentioned above. These results indicate that dietary pretreatment with clofibric acid suppressed the necrosis of hepatocytes in the initial stage, but not in the late stage ; rather, the recovery of liver from necrosis was delayed. Also this drug significantly suppressed fatty liver caused by CCl4.